Codexis, Inc. (CDXS) vs MediWound Ltd. (MDWD)

Codexis, Inc. and MediWound Ltd. are both Biotechnology companies. Codexis, Inc. and MediWound Ltd. are of similar size ($157.6M and $148.9M). Codexis, Inc. grew revenue faster over the last twelve months: 35.9% against −40.3%. Codexis, Inc. has the higher net margin (−39.6% vs −170.1%) and the higher return on invested capital (−151.2% vs −6,551.8%). Across the 18 metrics below, Codexis, Inc. leads on 16 and MediWound Ltd. on 2.

Valuation

Metric CDXS MDWD Biotechnology median
P/E n/m n/m 8.50
P/S 1.45 12.87 9.71
P/B 3.43 4.28 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.18 9.97 9.21
Earnings yield (27.42%) (13.50%) (33.15%)
Free cash flow yield (10.77%) (18.71%) (25.50%)

Profitability

Metric CDXS MDWD Biotechnology median
Gross margin 87.02% 15.46% 65.16%
Operating margin (35.61%) (267.75%) 0.00%
Net margin (39.55%) (170.10%) 0.00%
Free cash flow margin (15.66%) (240.47%) 0.00%
Return on equity (69.36%) (75.42%) (56.36%)
Return on assets (23.79%) (29.06%) (48.04%)
Return on invested capital (151.17%) (6,551.77%) 0.00%

Growth

Metric CDXS MDWD Biotechnology median
Revenue growth (TTM) 35.89% (40.26%) 6.02%
EPS growth (last fiscal year) 43.82% 30.69% 30.26%
Revenue growth, 5-year CAGR 0.38% (4.87%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDXS MDWD Biotechnology median
Debt to equity 1.03 0.00 0.00
Current ratio 3.06 2.32 4.72
Net debt to EBITDA 1.11 2.27 0.96

Dividend

Metric CDXS MDWD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CDXS MDWD Biotechnology median
Market cap 148.93m 157.63m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack